Wockhardt gets USFDA approval for marketing Metoprolol succinate
Bangalore, Jul 23 : Pharmaceutical and Biotechnology major Wockhardt has received final approval from the United States Food and Drug Administration (USFDA) for marketing 25mg, 50mg, 100mg and 200mg extended-release tablets of Metoprolol succinate, a cardiac drug.
Read more on New Kerala
Sanofi may buy Genzyme
Sanofi-Aventis SA made a takeover approach to Genzyme Corp. of Cambridge, the largest maker of medicines for genetic diseases, about two weeks ago, said two people with knowledge of the matter.
Elan suffers revenue dip despite rising MS drug sales
BIOPHARMA GROUP Elan reported lower revenue for the second quarter of the year as a rise in sales of multiple sclerosis drug Tysabri failed to offset declines on older drugs.
Read more on The Irish Times
Tags: approval, gets, Marketing, metoprolol, Succinate, USFDA, Wockhardt